These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8685466)

  • 1. [Assessment of residual mediastinal tumor in patients with Hodgkin's lymphoma using computed tomography, magnetic resonance and 67Ga scintigraphy].
    Capua A; Osti MF; Scattoni Padovan F; Sarra R; Sbarbati S; Anselmo AP; Maurizi Enrici R
    Radiol Med; 1995 Dec; 90(6):797-803. PubMed ID: 8685466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of magnetic resonance imaging and (67)gallium scintigraphy in the evaluation of posttherapeutic residual mediastinal mass in the patients with Hodgkin's lymphoma.
    Herman M; Paucek B; Raida L; Myslivecek M; Zapletalová J
    Eur J Radiol; 2007 Dec; 64(3):432-8. PubMed ID: 17478069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance imaging and 67Ga scan versus computed tomography in the staging and in the monitoring of mediastinal malignant lymphoma: a prospective pilot study.
    Bendini M; Zuiani C; Bazzocchi M; Dalpiaz G; Zaja F; Englaro E
    MAGMA; 1996; 4(3-4):213-24. PubMed ID: 9220410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bulky mediastinal lymphomas: role of magnetic resonance and SPECT-Ga-67 in the evaluation of residual masses].
    Canini R; Battista G; Monetti N; Pisi P; Fanti S; Zinzani PL; Zompatori M; Bendandi M; Gherlinzoni F; Corinaldesi A
    Radiol Med; 1995 Oct; 90(4):448-56. PubMed ID: 8552823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of gallium scan, computed tomography, and magnetic resonance in patients with mediastinal Hodgkin's disease.
    Devizzi L; Maffioli L; Bonfante V; Viviani S; Balzarini L; Gasparini M; Valagussa P; Bombardieri E; Santoro A; Bonadonna G
    Ann Oncol; 1997; 8 Suppl 1():53-6. PubMed ID: 9187430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gallium scan in the evaluation of post chemotherapy mediastinal residual masses of aggressive non-Hodgkin's lymphoma.
    Ulusakarya A; Lumbroso J; Casiraghi O; Koscielny S; Vantelon JM; Girinsky T; Tardivon A; Bourhis JH; Dartevelle P; Pico JL; Munck JN
    Leuk Lymphoma; 1999 Nov; 35(5-6):579-86. PubMed ID: 10609795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance imaging and 67gallium scan in mediastinal malignant lymphoma: a prospective pilot study.
    Abrahamsen AF; Lien HH; Aas M; Winderen M; Hager B; Kvaløy S; Elgjo RF; Nome O
    Ann Oncol; 1994 May; 5(5):433-6. PubMed ID: 8075050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current role of gallium scan and magnetic resonance imaging in the management of mediastinal Hodgkin lymphoma.
    Gasparini MD; Balzarini L; Castellani MR; Tesoro Tess JD; Maffioli LS; Petrillo R; Ceglia E; Musumeci R; Buraggi GL
    Cancer; 1993 Jul; 72(2):577-82. PubMed ID: 8319190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Semiology of the exploration of residual masses in the mediastinum using imaging techniques].
    Pallardó Calatayud Y; Ferrer Puchol MD; García Conde J
    Sangre (Barc); 1998 Feb; 43(1):83-6. PubMed ID: 9577187
    [No Abstract]   [Full Text] [Related]  

  • 10. [Magnetic resonance in the study of residual mediastinal masses after therapy of lymphoma].
    Davini O; Levis A; Garabello D; Foggetti MD; Depaoli L; Cirillo R; De Lucchi R; Orsucci L; Resegotti L
    Radiol Med; 1992 Mar; 83(3):230-6. PubMed ID: 1579671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Malignant lymphoma: magnetic resonance tomography findings in residual supradiaphragmatic space-occupying lesions].
    Stroszczynski C; Hosten N; Oellinger J; Spahn G; Amthauer H; Bittner RC; Hierholzer J; Ludwig WD; Felix R
    Rofo; 1999 Sep; 171(3):192-9. PubMed ID: 10520328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hodgkin's disease: internal mammary lymph nodes relapse diagnosed by gallium-67 scintigraphy.
    Ruíz Hernández G; Pallardó Y; García Conde J; Ramos D; Ampudia J; Castillo FJ; Romero C
    Nuklearmedizin; 1999 Apr; 38(3):90-4. PubMed ID: 10320995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone lymphoma: 67Ga scintigraphy and CT for prediction of outcome after treatment.
    Israel O; Mekel M; Bar-Shalom R; Epelbaum R; Hermony N; Haim N; Dann EJ; Frenkel A; Ben-Arush M; Gaitini D
    J Nucl Med; 2002 Oct; 43(10):1295-303. PubMed ID: 12368366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical relevance of gallium-67 scintigraphy in lymphoma before and after therapy.
    Delcambre C; Reman O; Henry-Amar M; Peny AM; Macro M; Cheze S; Génot JY; Tanguy A; Switsers O; Van HL; Couëtte JE; Leporrier M; Bardet S
    Eur J Nucl Med; 2000 Feb; 27(2):176-84. PubMed ID: 10755723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thallium-201 scintigraphy for assessment of a gallium-67-avid mediastinal mass following therapy for Hodgkin's disease.
    Harris EW; Rakow JI; Weiner M; Agress H
    J Nucl Med; 1993 Aug; 34(8):1326-30. PubMed ID: 8326393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 67Ga scintigraphy for the evaluation of recurrences and residual masses in patients with lymphoma.
    Setoain FJ; Pons F; Herranz R; Vidal-Sicart S; Lomeña F; Ayuso C; Montserrat E; Setoain J
    Nucl Med Commun; 1997 May; 18(5):405-11. PubMed ID: 9194081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of gallium-67-citrate single-photon emission computed tomography in biopsy-confirmed residual Hodgkin's disease in the mediastinum.
    Kostakoglu L; Yeh SD; Portlock C; Heelan R; Yao TJ; Niedzwiecki D; Larson SM
    J Nucl Med; 1992 Mar; 33(3):345-50. PubMed ID: 1740700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of 67Ga scintigraphy in localization of lymphoma.
    van Amsterdam JA; Kluin-Nelemans JC; van Eck-Smit BL; Pauwels EK
    Ann Hematol; 1996 Apr; 72(4):202-7. PubMed ID: 8624373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Residual mediastinal mass in malignant lymphoma: value of magnetic resonance imaging and gallium scan.
    Brice P; Rain JD; Frija J; Miaux Y; Marolleau JP; Tredaniel J; Ferme C; Hennequin C; Gisselbrecht C
    Nouv Rev Fr Hematol (1978); 1993 Aug; 35(4):457-61. PubMed ID: 8414967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of thoracic computed tomography in the detection of recurrent Hodgkin's disease.
    Heron CW; Husband JE; Williams MP; Cherryman GR
    Br J Radiol; 1988 Jul; 61(727):567-72. PubMed ID: 3408843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.